Delineation of erythropoiesis in normal and malignant bone marrow using monoclonal antibody AS-E1 directed against transferrin receptors (CD71)

European Journal of Haematology

Volumn 60, Issue 1, 1998, Pages 53-60

  Olesen, Gitte ^a   Carlsen, Ingrid ^a   Skovbo, Anni ^b   Hokland, Marianne ^b   Hokland, Peter ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Bone marrow; Erythropoiesis; Flow cytometry; Transferrin receptor

Indexed keywords

CD71 ANTIGEN; MONOCLONAL ANTIBODY; TRANSFERRIN RECEPTOR;

ARTICLE; BONE MARROW CANCER; CELL SELECTION; CONTROLLED STUDY; ERYTHROPOIESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIGHT SCATTERING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031963525     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1998.tb00996.x     Document Type: Article

References (22)

1. KLUIN-NELEMANS JC, VAN WERING ER, VAN'T VERR MB, VAN DER SCHOOT CE, ADRIAANSEN HJ, VAN DER BURGH FJ, GRATAMA JW. Pitfalls in the immunophenotyping of leukaemia and leukaemic lymphomas: survey of 9 years of quality control in the Netherlands. Br J Haematol 1996; 95: 692-699.
2. HOKLAND P, KERNDRUP G, GRIFFIN JD, ELLEGAARD J. Analysis of leukocyte differentiation antigens in blood and bone marrow from preleukemia (refractory anemia) patients using monoclonal antibodies. Blood 1986; 67: 898-902.
3. KRISTENSEN JS, HOKLAND P Monoclonal antibody ratios in malignant myeloid diseases: diagnostic and prognostic use in myelodysplastic syndromes. Br J Haematol 1990; 74: 270-276.
4. BONDE J, MEYER K, BROE MK, HOKLAND M, TURLEY H, HOKLAND P. Improved flow cytometric identification of myelopoiesis by the simultaneous labelling with CD13, CD14 and CD66 monoclonal antibodies. Br J Haematol 1996; 92: 269-279.
5. ROBINSON J, SIEFF C, DELIA D, EDWARDS PAW, GREAVES M. Expression of cell-surface HLA-DR, HLA-ABC and glycophorin during erythroid differentiation. Nature 1981; 289: 68-71.
6. PESCHEL C, KONWALINKA G, GEISSLER D, BRAUNSTEINER H, KNAPP W. Changes of the phenotype of erythroid progenitor cells (BFU-E, CFU-E) and their progenies during early steps of differentiation. Br J Haematol 1987; 65: 131-135.
7. LOKEN MR, SHAH VO, DATTILIO KL, CIVIN CI, CLEVELAND RP, LIU YC. Flow cytometric analysis of human bone marrow: I. Normal erythroid development. Blood 1987; 69: 255-263.
8. SIEFF C, BICKNELL D, CAINE G, ROBINSON J, LAM G, GREAVES MF. Changes in cell surface antigen expression during hemopoietic differentiation. Blood 1982; 60: 703-713.
9. NAKAHATA T, OKUMURA N. Cell surface antigen expression in human erythroid progenitors: erythroid and megakaryocytic markers. Leuk Lymph 1994; 13: 401-409.
10. ROGERS CE, BRADLEY MS, PALSSON BO, KOLLER MR. Flow cytometric analysis of human bone marrow perfusion cultures: erythroid development and relationship with burst-forming units-erythroid. Exp Hematol 1996; 24: 597-604.
11. GATTER KC, BROWN G, TROWBRIDGE IS, WOOLSTON RE, MASON DY. Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol 1983; 36: 539-545.
12. KOZLOWSKI R, REILLY IA, SOWTER D, ROBINS RA, RUSSELL NH. Transferrin receptor expression of AML blasts is related to their proliferativc potential. Br J Haematol 1988; 69: 275-280.
13. SCOTT CS, RAMSDEN W, LIMBERT HJ, MASTER PS, ROBERTS BE. Membrane transferrin receptor (TfR) and nuclear proliferation-associated Ki-67 expression in hemopoietic malignancies. Leukemia 1988; 2: 438-442.
14. HABESHAW JA, LISTER TA, STANSFELD AG, GREAVES MF. Correlation of transferrin receptor expression with histological class and outcome in non-Hodgkin lymphoma. Lancet 1983; 1: 498-501.
15. SHINDELMAN JE, ORTMEYER AE, SUSSMAN HH. Demonstration of the transferrin receptor in human breast cancer tissue. Potential marker for identifying dividing cells. Int J Cancer 1981; 27: 329-334.
16. MADSEN PS, HOKLAND M, ELLEGAARD J, HOKLAND P, RATZ GP, CELIS A, CELIS JE. Major proteins in normal human lymphocyte subpopulations separated by fluorescence-activated cell sorting and analyzed by two-dimensional gel electrophoresis. Leukemia 1988; 2: 602-615.
17. GRIFFIN JD, LINCH D, SABBATH K, LARCOM P, SCHLOSSMAN SF. A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells. Leuk Res 1984; 8: 521-534.
18. BORDESSOULE D, JONES M, GATTER KC, MASON DY. Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67. Br J Haematol 1993; 83: 370-383.
19. REINHERZ EL, KUNG PC, GOLDSTEIN G, LEVY RH, SCHLOSSMAN SF. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T lineage. Proc Natl Acad Sci USA 1980; 58: 954.
20. HOKLAND P, ROSENTHAL P, GRIFFIN JD, et al. Purification and characterization of fetal hematopoietic cells which express the common acute lymphoblastic leukemia antigen (CALLA). J Exp Med 1983; 157: 114-129.
21. TERSTAPPEN LWMM, LOKEN MR. Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry. Analyt Cell Pathol 1990; 2: 229-240.
22. TERSTAPPEN LWMM, MICKAELS R, DOST R, LOKEN MR. Increased light scattering resolution facilitates multidimensional flow cytometric analysis. Cytometry 1990; 11: 506-512.